J. Gil-Moradillo

Papers

Total Citations

H-Index

About

J. Gil-Moradillo is a leading urological surgeon and researcher whose work centers on advancing minimally invasive treatments for benign prostatic hyperplasia (BPH). His major contribution lies in directly comparing the efficacy of two cutting-edge techniques: holmium laser enucleation (HoLEP) and robot-assisted simple prostatectomy (RASP) for large-volume prostates. In his landmark 2025 study, he meticulously analyzed perioperative outcomes, functional results, quality of life, and complication rates between these approaches, providing crucial evidence to guide surgical decision-making. This work, already garnering 3 citations in its first year, fills a critical gap in urological literature by offering head-to-head data on these complex procedures. Gil-Moradillo’s research is particularly valuable for surgeons treating patients with significantly enlarged prostates, where traditional approaches carry higher risks. His findings help clarify which patients benefit most from each technique, balancing factors like recovery time, symptom relief, and complication profiles. By systematically evaluating both laser and robotic platforms, he is helping define the modern standard of care for large-volume BPH, making his work essential reading for urologists and trainees seeking to optimize surgical outcomes in this challenging patient population.